心房颤动筛查:AF-SCREEN国际合作组织报告
AF-SCREEN国际合作组织于2015年成立,2016年通过专家讨论和Delphi流程形成本白皮书,指出单次或2周间歇心电图检出的房颤并非良性, handheld ECG设备因提供可验证心电图轨迹而更适合筛查,筛查需与诊疗路径衔接,且应因地制宜。
要点
- 单次或2周间歇心电检出房颤伴卒中危险因素时,卒中风险足以考虑抗凝。
- 手持心电设备提供可验证心电轨迹,符合指南诊断要求,宜作为筛查工具。
- 筛查场景应结合各国卫生资源与体系,并与诊断管理路径衔接。
核心结论
- 基于现有知识,本白皮书为当前开展房颤筛查提供了有力依据,同时认识到大型随机结局研究有助于强化证据基础。
研究设计与样本
- AF-SCREEN国际合作组织于2015年9月成立,2016年60名专家受邀撰写草案,51名成员在罗马开会讨论并用Delphi流程形成关键点。
主要发现
- 约10%的缺血性卒中与卒中时首次诊断的房颤相关。
- 单次或2周间歇心电记录检出的房颤并非良性,伴额外卒中因素时卒中风险足以考虑抗凝。
- 手持心电设备提供可验证心电轨迹,符合指南诊断要求,宜优先作为筛查工具。
- 近期不明来源栓塞性卒中(ESUS)等特定患者组需要更密集的房颤监测。
临床怎么用
- 筛查环境包括社区和诊所多种场所,但必须与适当诊断和管理路径衔接才能使筛查有效。
- 各国和卫生系统资源差异大,房颤筛查场景应因国家和卫生系统而异。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Approximately 10% of ischemic strokes are associated with atrial fibrillation (AF) first diagnosed at the time of stroke. Detecting asymptomatic AF would provide an opportunity to prevent these strokes by instituting appropriate anticoagulation. The AF-SCREEN international collaboration was formed in September 2015 to promote discussion and research about AF screening as a strategy to reduce stroke and death and to provide advocacy for implementation of country-specific AF screening programs. During 2016, 60 expert members of AF-SCREEN, including physicians, nurses, allied health professionals, health economists, and patient advocates, were invited to prepare sections of a draft document. In August 2016, 51 members met in Rome to discuss the draft document and consider the key points arising from it using a Delphi process. These key points emphasize that screen-detected AF found at a single timepoint or by intermittent ECG recordings over 2 weeks is not a benign condition and, with additional stroke factors, carries sufficient risk of stroke to justify consideration of anticoagulation. With regard to the methods of mass screening, handheld ECG devices have the advantage of providing a verifiable ECG trace that guidelines require for AF diagnosis and would therefore be preferred as screening tools. Certain patient groups, such as those with recent embolic stroke of uncertain source (ESUS), require more intensive monitoring for AF. Settings for screening include various venues in both the community and the clinic, but they must be linked to a pathway for appropriate diagnosis and management for screening to be effective. It is recognized that health resources vary widely between countries and health systems, so the setting for AF screening should be both country- and health system-specific. Based on current knowledge, this white paper provides a strong case for AF screening now while recognizing that large randomized outcomes studies would be helpful to strengthen the evidence base.
引用
- Freedman B, Camm J, Calkins H, et al. Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. Circulation. 2017. PMID: 28483832. doi:10.1161/CIRCULATIONAHA.116.026693
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。